Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Deferataj 500mg Tablet DT

Prescription Icon
Prescription Required

Marketer

Taj Pharma India Ltd

Salt Composition

Deferasirox (500mg)

Overview Deferataj 500mg Tablet DT

Iron overload from repeated blood transfusions is treated with Deferataj 500mg Tablet DT. This medication facilitates iron excretion, mitigating potential organ damage. Administer Deferataj 500mg Tablet DT on an empty stomach, adhering precisely to the prescribed dosage and schedule for optimal efficacy. Common side effects include nausea, headache, constipation, and diarrhea; persistent or worsening symptoms warrant medical attention. Prior to commencing treatment, disclose any pre-existing liver or kidney conditions, and provide a complete list of all other medications currently in use to ensure treatment safety.

Uses of Deferataj 500mg Tablet DT

Managing excess iron in the body

Major Benefits of Deferataj 500mg Tablet DT:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dissolve the Deferataj 500mg Tablet DT in water before consumption. Administer on an empty stomach.

Common Side effects of Deferataj 500mg Tablet DT:

  • Nausea
  • Headache
  • Vomiting
  • Rash
  • Abdominal pain
  • Constipation
  • Itching
  • Abdominal distension
  • Diarrhea

How to use Deferataj 500mg Tablet DT:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Deferataj 500mg Tablet DT in water before consumption. Administer on an empty stomach.

How Deferataj 500mg Tablet DT works:

Deferasirox 500mg Delayed-Release tablets bind and eliminate surplus iron, primarily through fecal excretion. This mitigates the potential for organ injury.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Deferataj 500mg Tablet DT is not established as safe. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Deferataj 500mg Tablet DT during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Breastfeeding mothers can likely use Deferataj 500mg Tablet DT safely. Available human data indicates minimal infant risk from this medication.

DrivingDrivingUNSAFE

Taking a 500mg Deferataj DT tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyUNSAFE

The use of Deferataj 500mg Tablet DT is likely inadvisable for individuals with impaired kidney function and should be avoided. Seek medical advice before taking this medication.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Deferataj 500mg Tablet DT; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Deferataj 500mg Tablet DT :

Should you forget a Deferataj 500mg Tablet DT dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Deferataj 500mg Tablet DT

LabelValue
Chemical Category Benzoate-triazole hybrid
Developing Habits No.
Treatment Category KINSHIP

FAQs on Deferataj 500mg Tablet DT

Deferasirox 500mg tablets (DT) treat iron overload in beta-thalassemia major patients resulting from frequent blood transfusions.
Deferasirox 500mg tablets (DT) eliminate excess iron from the bloodstream, facilitating its excretion in the stool.
Deferataj 500mg Tablet DT
401
MRP 488
17% off